I


IDHIFA® (01-17-2018)

Generic Name: enasidenib Trade Name: IDHIFA® For which conditions is this drug approved? IDHIFA is indicated for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation as detected... Continue Reading

inotuzumab ozogamicin (01-17-2018)

Generic Name: inotuzumab ozogamicin Trade Name: BESPONSA For which conditions is this drug approved? BESPONSA is indicated for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The labeling contains... Continue Reading

Imuran® (06-9-2017)

Class: Biologic Therapy Generic Name: azathioprine Trade Name: Imuran®, Azasan® How is this drug used? Azathioprine is approved as a supplementary for the prevention of renal transplantation failure, and for adults with active rheumatoid arthritis... Continue Reading

Imfinzi™ (06-9-2017)

Class: Biological Therapy Generic Name: durvalumab Trade Name: Imfinzi For which conditions is this drug approved? Durvalumab is used for patients with bladder or urinary tract cancer that cannot be removed by surgery or has spread to other parts of... Continue Reading

infliximab-dyyb (06-9-2017)

Class: Biological Therapy Generic Name: infliximab-dyyb Trade Name: Inflectra® How is this drug used? Inflectra is approved for the treatment of adults with moderate to severe rheumatoid arthritis (RA) in combination with methotrexate; for adults... Continue Reading

Inflectra® (06-9-2017)

Class: Biological Therapy Generic Name: infliximab-dyyb Trade Name: Inflectra® How is this drug used? Inflectra is approved for the treatment of adults with moderate to severe rheumatoid arthritis (RA) in combination with methotrexate; for adults... Continue Reading

infliximab (06-1-2017)

Class: Biological Therapy Generic Name: infliximab Trade Name: Remicade® How is this drug used? Remicade is used for selected patients with Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or... Continue Reading

idarucizumab (05-17-2016)

Class: Biologic Therapy Generic Name: idarucizumab Trade Name: Praxbind For which conditions is this drug approved? Praxbind® is indicated for patients specifically treated with Pradaxa® (dabigatran etexilate mesylate), an anti-clotting agent, when... Continue Reading

irinotecan liposome injection (04-12-2016)

Class: Chemotherapy Generic Name: irinotecan liposome injection Trade Name: Onivyde For which conditions is this drug approved? Onivyde in combination with fluorouracil and leucovorin is indicated for the treatment of patients with metastatic pancreatic... Continue Reading

Imlygic™ (04-6-2016)

Class: Viral Therapy Generic Name: talimogene laherparepvec Trade Name: Imlygic For which conditions is this drug approved? Imlygic can be used to treat melanomas in the skin or lymph nodes that can’t be removed with surgery. What is the mechanism... Continue Reading

Next Page »